The Long-term Clinical Results of a Platelet Glycoprotein IIb/IIIa Receptor Blocker (Abciximab: ReoPro(®)) Coated Stent in Patients with Coronary Artery Disease

BACKGROUND : Previously, the inhibition of coronary restenosis with Abciximab (ReoPro(®))-coated stent in a porcine model was reported. ReoPro(®) inhibits platelet aggregation, the proliferation of vascular smooth muscle cells and the inflammatory reaction. METHODS : A prospective randomized trial w...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Weon, Jeong, Myung Ho, Hong, Young Joon, Lee, Seng Hyun, Park, Woo Seok, Kim, Ju Han, Kim, In Soo, Choi, Myung Ja, Ahn, Young Keun, Cho, Jeong Gwan, Park, Jong Chun, Cho, Dong Lyun, Kim, Hoon, Kang, Jung Chaee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Internal Medicine 2004
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531572/
https://www.ncbi.nlm.nih.gov/pubmed/15683110
http://dx.doi.org/10.3904/kjim.2004.19.4.220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531572/
https://www.ncbi.nlm.nih.gov/pubmed/15683110
http://dx.doi.org/10.3904/kjim.2004.19.4.220

Ejemplares similares